Aggrecan, together with type II collagen, makes up to 90% of the dry weight of healthy cartilage. It hydrates the collagen network and thus provides cartilage with its properties of compressibility and elasticity. The N-terminal region of human Aggrecan (residues 20-675) consists of two globular domains (G1 and G2), flanking an interglobular domain (IGD). The IGD contains the cleavage sites for matrix metalloproteinases and aggrecanases.
應用類型
WB, IHC (P)
免疫原
該Anti-Human Aggrecan的詳細信息查看ReliaTech提供的產品說明書。
來源宿主
該Anti-Human Aggrecan的詳細信息查看ReliaTech提供的產品說明書。
反應性
該Anti-Human Aggrecan的詳細信息查看ReliaTech提供的產品說明書。
保存建議
該Anti-Human Aggrecan的詳細信息查看ReliaTech提供的產品說明書。溶解建議：Centrifuge vial prior to opening. Reconstitute the antibody with 500 μl sterile PBS and the final concentration is 200 μg/ml.
